首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >N-(4-[~18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl) piperazin-l-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HTia receptors
【24h】

N-(4-[~18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl) piperazin-l-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HTia receptors

机译:N-(4- [〜18F] - 氟吡啶-2-基)-N- {2- [4-(2-甲氧基苯基)哌嗪-1-基]甲基}甲酰胺作为Way100635的类似物。 血清素5-HTIA受体的新宠物跟踪器

获取原文
获取原文并翻译 | 示例
           

摘要

N-(4-[~18F]-Fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-l-yl]ethyl}-carboxamides were prepared by labeling their 4-nitropyridin-2-yl precursors through nitro substitution by the ~18F anion. In vitro and in vivo tests showed that the cyclohexanecarboxamide derivative is a reversible, selective and high affinity 5-HTia receptor antagonist (IC50 = 0.29 nM, k_i= 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional standards. This PET radio-ligand is a promising candidate for an improved in vivo quantification of 5-HT_1A receptors in neuro-psychiatric disorders.
机译:通过标记其4-硝基吡啶-2,制备N-(2- [4-(2-(2-甲氧基苯基)哌嗪-1- y1]乙基乙基乙基} -Carboblamide。 通过〜18F阴离子通过硝基取代的前体。 体外和体内试验表明,环己羧酰胺衍生物是可逆,选择性和高亲和力的5-HTIA受体拮抗剂(IC50 = 0.29nm,K_I = 0.18nm),与高脑摄取,慢脑间隙和稳定性 常规标准。 该宠物无线电配体是神经精神病疾病中5-HT_1A受体的改进的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号